- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Total DTcP and combined vaccination market size in China 2017-2030
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Total DTcP and combined vaccination market size in China 2017-2030
DTcP and combined vaccine (DTaP-Hib and DTcP-Hib-Polio) market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
by Statista Research Department,
last edited
Mar 8, 2019
This statistic shows the total DTcP (diphtheria/tetanus/pertussis) and combined vaccine (DTaP-Hib and DTcP-Hib-Polio) market size in China in 2017 with projections until 2030. By 2030, China's DTcP and combined vaccination market size was forecasted to grow up to 8.15 billion yuan in total.
DTcP and combined vaccine (DTaP-Hib and DTcP-Hib-Polio) market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
| Market size in billion yuan | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Market size in billion yuan | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Mar 8, 2019
This statistic shows the total DTcP (diphtheria/tetanus/pertussis) and combined vaccine (DTaP-Hib and DTcP-Hib-Polio) market size in China in 2017 with projections until 2030. By 2030, China's DTcP and combined vaccination market size was forecasted to grow up to 8.15 billion yuan in total.
- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- China
- Survey time period
- 2017
- Supplementary notes
-
*Forecast.
Note: 1 yuan equals approximately 0.15 U.S. dollars and 0.13 euros (as of March 2019).
Figures have been rounded.
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- China
- Survey time period
- 2017
- Supplementary notes
-
*Forecast.
Note: 1 yuan equals approximately 0.15 U.S. dollars and 0.13 euros (as of March 2019).
Figures have been rounded.
Other statistics on the topic
+Pharmaceutical Products & Market
Leading pharmaceutical companies and total global vaccine revenue 2017 and 2024
State of Health
New cases of measles in the U.S. 1950-2019
State of Health
MMR vaccination rate among U.S. children aged 19-35 months 1994-2017
+Pharmaceutical Products & Market
Leading five global vaccine products by revenue 2017 and 2024
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Vaccinations in the U.S."
- Global overview
The most important statistics
- Routine vaccination coverage globally as of 2017, by vaccine type*Global vaccination coverage in 2017, by vaccine type
- Percentage of measles immunization among 1-year-olds worldwide in 2017, by regionPercentage of measles immunization among 1-year-olds by world region 2017
- Percentage of one-year-olds who have diphtheria, tetanus, and pertussis vaccination (DTP3) worldwide in 2017, by regionOne-year-olds who have DTP3 vaccination by world region 2017
- Vaccination coverage against influenza among the elderly in OECD countries as of 2015Vaccination coverage against influenza among older people 2015
- Top 10 pharmaceutical companies based on global vaccine revenues in 2017 and 2024 (in million U.S. dollars)Leading pharmaceutical companies and total global vaccine revenue 2017 and 2024
- Top 5 global vaccine products based on revenue in 2017 and 2024 (in million U.S. dollars)Leading five global vaccine products by revenue 2017 and 2024
- Percentage of respondents in select countries worldwide who believed some vaccines cause autism in healthy children as of 2017Share of people worldwide who believed vaccines can cause autism as of 2017
- U.S. vaccination impact
The most important statistics
- Annual number of cases of select infectious diseases in the U.S. before and after the development and use of vaccinations as of 2009Cases of infectious diseases before and after the use of vaccines U.S. 2009
- Number of new cases of measles (rubeola) in the U.S. from 1950 to 2019New cases of measles in the U.S. 1950-2019
- Number of new cases of hepatitis A and B in the U.S. from 1970 to 2016New cases of hepatitis in the U.S. 1970-2016
- New cases of hepatitis A and B per 100,000 population in the U.S. from 1970 to 2016New cases of hepatitis A and B 1970-2016
- New cases of diphtheria per 100,000 population in the U.S. from 1950 to 2016*New cases of diphtheria in the U.S. 1950-2016
- New cases of mumps per 100,000 population in the U.S. from 1970 to 2016New cases of mumps in the U.S. 1970-2016
- Children and adolescents
The most important statistics
- Percentage of children aged 19-35 months who are vaccinated against measles, mumps and rubella (MMR) in the U.S. from 1994 to 2017MMR vaccination rate among U.S. children aged 19-35 months 1994-2017
- Percentage of U.S. children aged 19-35 months who received all doses of recommended vaccines in 2017Share of U.S. children who received all doses of recommended vaccines 2017
- Percentage of adolescents in the U.S. aged 13 to 17 years who had received select vaccinations in 2017 and 2018Share of U.S. teenagers who had select vaccinations 2017-2018
- Percentage of adolescents in the U.S. who had received select vaccinations as of 2018, by ageVaccination coverage among U.S. adolescents as of 2018, by age
- Percentage of adolescents in the U.S. who had received a Tdap vaccination as of 2017, by state*Tdap vaccination rates among U.S. adolescents as of 2017, by state
- Percentage of adolescents in the U.S. who had received a MenACWY vaccination as of 2017, by state*MenACWY vaccination rates among U.S. adolescents as of 2017, by state
- States with the lowest percentage of children receiving recommended immunizations in the U.S. as of 2018*U.S. states with the lowest percent of children receiving vaccinations U.S. 2018
- Adults
The most important statistics
- Percentage of U.S. college students that had received select vaccinations as of fall 2018U.S. college students that had received select vaccinations as of fall 2018
- Percentage of older people who received an influenza vaccination during the past 12 months in the U.S. from 1997 to 2018Percentage of U.S. older people who received influenza vaccination 1997-2018
- States with the highest rates of older females who received a flu vaccine in the past year in the U.S. in 2017U.S. states with the highest rate of flu vaccine receiving older women 2017
- Percentage of older people who had ever received a pneumococcal vaccination in the U.S. from 1997 to 2018Percentage of older U.S. people who received a pneumococcal vaccination 1997-2018
- Injury and death from vaccines
The most important statistics
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019*Number of petitions filed for injury or death caused by vaccines U.S. 1988-2019
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019, by outcome*Number of petitions filed for damages caused by vaccines U.S. 1988-2019, by outcome
- Number of petitions filed per year seeking compensation for injury or death caused by vaccines in the U.S. from 1988 to 2019Number of petitions filed per year for damages caused by vaccines U.S. 1988-2019
- Percentage of adverse drug event in U.S. hospitals that are attributed to select medications in 2014, by drug type*Percentage of U.S. averse drug events in US hospitals 2014, by drug type
- Public opinion
The most important statistics
- Percentage of U.S. adults that believed vaccines were important to the health of society as of 2018U.S. adult thoughts on the importance of vaccines to societal health as of 2018
- Percentage of U.S. adults who were confident in the U.S. system of evaluating the safety of vaccinations and recommendations in the U.S. in 2008 and 2018Confidence in vaccination recommendations and approvals in the U.S. in 2008 and 2018
- Percentage of U.S. adults that believed they had personally benefitted from the development of vaccines over the past 50 years in 2008 and 2018U.S. adults who felt they benefited from vaccines as of 2008 and 2018
- Percentage of U.S. adults that had select opinions on the importance of parents vaccinating their children as of 2018Opinions on the importance of childhood vaccinations in the U.S. as of 2018
- Percentage of U.S. adults that felt it was important for parents to vaccinate their children in 2008 and 2018Opinions on the importance of childhood vaccinations in the U.S. 2008 vs. 2018
- Percentage of U.S. adults that believed when one child is not vaccinated it puts other children at risk as of 2018Opinions on risk from unvaccinated children in the U.S. as of 2018
- Focus: Human papillomavirus (HPV)
The most important statistics
- Percentage of adolescents in the U.S. aged 13 to 17 years who had received a human papillomavirus (HPV) vaccination as of 2018, by genderShare of U.S. teenagers who had an HPV vaccination 2018, by gender
- Percentage of male adolescents in the U.S. who had received an HPV vaccine as of 2018, by age*HPV vaccine coverage among U.S. male adolescents as of 2018, by age
- Percentage of female adolescents in the U.S. who had received an HPV vaccine as of 2018, by age*HPV vaccine coverage among U.S. female adolescents as of 2018, by age
- Percentage of adolescents in the U.S. aged 13 to 17 years who had received a human papillomavirus (HPV) vaccination as of 2017, by poverty level Share of U.S. teenagers who had an HPV vaccination 2017, by poverty level
- Percentage of adolescents in the U.S. who had received an HPV vaccination as of 2017, by state*HPV vaccination rates among U.S. adolescents as of 2017, by state
- Major factors contributing to HPV vaccine underutilization as reported by U.S. health care professionals as of 2016Reasons for underutilization of the HPV vaccine in the U.S. 2016
- Miscellaneous
The most important statistics
- Percentage of older U.S. adults who stated that a flu vaccination should definitely be required for select staff in nursing homes as of 2017*Opinions on flu vaccination requirements for U.S. nursing home staff as of 2017
- Percentage of U.S. adults that would be less likely to select a nursing facility if 1/3 of the staff did not get a flu vaccine as of 2017*Likelihood of selecting a U.S. nursing home based on flu vaccine rates of staff 2017
- Percentage of employers in the U.S. that offered select wellness programs and events as of 2019Share of U.S. employers that offered select wellness programs in 2019
- Number of U.S. states that improved health prevention and treatment from 2018 to 2019Number of states that improved health prevention and treatment 2019
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Total DTaP vaccination market size in China 2017-2030
- Total lot release volume of public DTP vaccinations in China 2017-2030
- Total lot release volume of private DTP vaccinations in China 2017-2030
- Total DTP vaccination market size in China 2017-2030
- Total lot release volume of DTP vaccinations in China 2017-2030
- Pneumococcal conjugate vaccination market size in China 2017-2030
- Total meningococcal vaccination market size in China 2017-2030
- Total lot release volume of pneumococcal vaccinations in China 2017-2030
- Pneumococcal polysaccharide vaccination market size in China 2017-2030
- Total pneumococcal vaccination market size in China 2017-2030
- Total lot release volume of private meningococcal vaccinations in China 2017-2030
- Total lot release volume of public meningococcal vaccinations in China 2017-2030
- Total lot release volume of meningococcal vaccinations in China 2017-2030
- Total lot release volume of vaccinations in China 2013-2030
- Global vaccine market share by administration route 2028 forecast
- Basic vaccines: revenues in selected countries 2013
- India: vaccine market value by segment 2012
- Global veterinary clostridium vaccine market share by animal 2016
- Size of the total global vaccine market 2014-2024
- Size of the U.S. vaccine market by age 2014-2024
Studies
- Vaccine hesitancy in the U.S.
- Vaccinations in the U.S.
- Vaccinations in Canada
- Vaccinations in Italy
- Transforming India's Vaccine Market
- Vaccine industry in China
- Sanofi
- PhRMA - Vaccine Fact Book 2013
- Zoetis Annual Report 2018
- Zoetis
- Market Insight Animal Health
- Childhood Immunisation Statistics, Scotland 2016
- Childhood Immunisation Statistics, Scotland 2014
- Childhood Immunisation Statistics, Scotland 2015
- GlaxoSmithKline - Annual Report 2018
Statistics on "Vaccinations in the U.S."
- Routine vaccination coverage globally as of 2017, by vaccine type*
- Percentage of measles immunization among 1-year-olds worldwide in 2017, by region
- Percentage of one-year-olds who have diphtheria, tetanus, and pertussis vaccination (DTP3) worldwide in 2017, by region
- Vaccination coverage against influenza among the elderly in OECD countries as of 2015
- Top 10 pharmaceutical companies based on global vaccine revenues in 2017 and 2024 (in million U.S. dollars)
- Top 5 global vaccine products based on revenue in 2017 and 2024 (in million U.S. dollars)
- Percentage of respondents in select countries worldwide who believed some vaccines cause autism in healthy children as of 2017
- Annual number of cases of select infectious diseases in the U.S. before and after the development and use of vaccinations as of 2009
- Number of new cases of measles (rubeola) in the U.S. from 1950 to 2019
- Number of new cases of hepatitis A and B in the U.S. from 1970 to 2016
- New cases of hepatitis A and B per 100,000 population in the U.S. from 1970 to 2016
- New cases of diphtheria per 100,000 population in the U.S. from 1950 to 2016*
- New cases of mumps per 100,000 population in the U.S. from 1970 to 2016
- Percentage of children aged 19-35 months who are vaccinated against measles, mumps and rubella (MMR) in the U.S. from 1994 to 2017
- Percentage of U.S. children aged 19-35 months who received all doses of recommended vaccines in 2017
- Percentage of adolescents in the U.S. aged 13 to 17 years who had received select vaccinations in 2017 and 2018
- Percentage of adolescents in the U.S. who had received select vaccinations as of 2018, by age
- Percentage of adolescents in the U.S. who had received a Tdap vaccination as of 2017, by state*
- Percentage of adolescents in the U.S. who had received a MenACWY vaccination as of 2017, by state*
- States with the lowest percentage of children receiving recommended immunizations in the U.S. as of 2018*
- Percentage of U.S. college students that had received select vaccinations as of fall 2018
- Percentage of older people who received an influenza vaccination during the past 12 months in the U.S. from 1997 to 2018
- States with the highest rates of older females who received a flu vaccine in the past year in the U.S. in 2017
- Percentage of older people who had ever received a pneumococcal vaccination in the U.S. from 1997 to 2018
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019*
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019, by outcome*
- Number of petitions filed per year seeking compensation for injury or death caused by vaccines in the U.S. from 1988 to 2019
- Percentage of adverse drug event in U.S. hospitals that are attributed to select medications in 2014, by drug type*
- Percentage of U.S. adults that believed vaccines were important to the health of society as of 2018
- Percentage of U.S. adults who were confident in the U.S. system of evaluating the safety of vaccinations and recommendations in the U.S. in 2008 and 2018
- Percentage of U.S. adults that believed they had personally benefitted from the development of vaccines over the past 50 years in 2008 and 2018
- Percentage of U.S. adults that had select opinions on the importance of parents vaccinating their children as of 2018
- Percentage of U.S. adults that felt it was important for parents to vaccinate their children in 2008 and 2018
- Percentage of U.S. adults that believed when one child is not vaccinated it puts other children at risk as of 2018
- Percentage of adolescents in the U.S. aged 13 to 17 years who had received a human papillomavirus (HPV) vaccination as of 2018, by gender
- Percentage of male adolescents in the U.S. who had received an HPV vaccine as of 2018, by age*
- Percentage of female adolescents in the U.S. who had received an HPV vaccine as of 2018, by age*
- Percentage of adolescents in the U.S. aged 13 to 17 years who had received a human papillomavirus (HPV) vaccination as of 2017, by poverty level
- Percentage of adolescents in the U.S. who had received an HPV vaccination as of 2017, by state*
- Major factors contributing to HPV vaccine underutilization as reported by U.S. health care professionals as of 2016
- Percentage of older U.S. adults who stated that a flu vaccination should definitely be required for select staff in nursing homes as of 2017*
- Percentage of U.S. adults that would be less likely to select a nursing facility if 1/3 of the staff did not get a flu vaccine as of 2017*
- Percentage of employers in the U.S. that offered select wellness programs and events as of 2019
- Number of U.S. states that improved health prevention and treatment from 2018 to 2019
- DTaP (diphtheria/tetanus/pertussis) vaccine market size in China from 2017 to 2030, based on sales revenue (in million yuan)
- DTP (diphtheria/tetanus/pertussis) vaccine lot release volume for public market in China from 2017 to 2030 (in million doses)
- DTP (diphtheria/tetanus/pertussis) vaccine lot release volume for private market in China from 2017 to 2030 (in million doses)
- DTP (diphtheria/tetanus/pertussis) vaccine market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- DTP (diphtheria/tetanus/pertussis) vaccine lot release volume in China from 2017 to 2030 (in million doses)
- Pneumococcal conjugate vaccine (PCV13) market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- Meningococcal vaccine market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- Pneumococcal vaccine lot release volume for private market in China from 2017 to 2030 (in million doses)
- Pneumococcal polysaccharide vaccine (PPV23) market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- Pneumococcal vaccine market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- Meningococcal vaccine lot release volume for private market in China from 2017 to 2030 (in million doses)
- Meningococcal vaccine lot release volume for public market in China from 2017 to 2030 (in million doses)
- Meningococcal vaccine lot release volume in China from 2017 to 2030 (in million doses)
- Vaccine lot release volume in China from 2013 to 2030 (in million doses)
- Percentage of the global vaccine market in 2017 and a forecast for 2028, by route of administration
- Vaccine market revenues in selected countries as of 2013 (in billion U.S. dollars)
- Indian vaccine market value in 2012, by segment (in million U.S. dollars)
- Global veterinary clostridium vaccine market share in 2016, by species
- Total global vaccine market size from 2014 to 2024 (in billion U.S. dollars)
- Vaccine market size in the U.S. from 2014 to 2024, by age group (in billion U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.